With the advent of higher medical care costs and productivity concerns increasing at more worksites in the past decade, a growing number of companies have developed in-house medical clinics with occupational health nurses, nurse practitioners, and other allied health professionals. These clinics exist in both mid-sized and large organizations. According to some of these companies, on-site medical clinics make sense to them in terms of both cost-containment and quality of health care provided to their employees. 1 For example, an external audit of one company's on-site clinics found that employees used fewer outpatient and inpatient services when adjusted by age, gender, and other demographics, than their peers in the community. M oreover, the company's database showed the costs to run the clinic are significantly less than what the health plan would have been paying if employees were to have used community health care providers. 2 Similarly, other organizations report their health care costs have risen just 6% annually over the past four years, translating into corporate health care spending that is 17% less than industry-related averages; another organization reported its on-site clinics saves the company more than one million dollars per year. 3 In early 2004, officials of a southeastern US industrial metal/plastics manufacturing firm and Carolinas
Healthcare System (CHS) engaged in a contract to offer nurse practitioner (NP) services at the firm's (1) administrative, (2) plastics, and (3) foundry locations. On June 17, 2004, a nurse practitioner was hired by CHS and placed at the firm to begin her official duties. The NP's official workload was distributed as follows:
• 18 hours per week devoted to plastics division employees
• 18 hours per week devoted to foundry division employees
• 4 hours per week devoted to administrative division employees
The primary goal of the NP is to provide primary care services to employees in a timely and costefficient manner. The scope of her services includes writing prescriptions, administering medications, and establishing treatment modalities for chronic conditions. Currently, only employees are eligible to receive onsite medical care services from the NP at no out-of-pocket expense.
Prior to the NP placement, employees and dependents with health plan coverage obtained all medical care from off-site medical care providers. However, since April 1, 2004, a 24/7 nurse advice line provided by CHS has been available to employees and dependents. The nurse advice line is primarily designed to (1) assist employees in selecting appropriate on-site and off-site medical care and (2) eliminate unnecessary emergency department visits.
In order to determine the impact on the new NP placement on the firm's medical care expenses, CHS retained the services of Chenoweth & Associates, Inc. (C&A).
Methods
Based on the primary purpose of the NP initiative and the type of pre-and post-initiative data available to C&A, a benefit-cost analysis framework was used to evaluate the initial impact of the NP intervention. The primary purpose of benefit-cost analysis (BCA) is to determine whether a program is worth its cost. 4 In essence,
BCA is an economic tool with an emphasis on estimating the monetary value of everything. The monetary value of a project rests on two fundamental postulates:
The social value of an intervention is the sum of the values of the project to the individual members of society [workplace]
Postulate 2:
The value of an intervention to an individual is equal to his (fully informed) willingness to pay for the intervention.
M aking value judgments about the desirability of economic states is the thrust of welfare economics and the choice of a decision criterion is critical. A guiding rule in formulating criteria, at least in Western society, is that each individual's preferences must (somehow) count in the evaluation of alternative economic states. While there are four popular decision criteria (Unanimity, Pareto Superiority, M ajority Rule, Potential Pareto Superiority), the criterion used in benefit-cost analysis is the Potential Pareto Superiority criterion. It states that an increase in general welfare occurs if those that are made better off and still from some change could, in principle, fully compensate those that are made worse off and still achieve in welfare improvement. While this criterion provides the basis for the quantitative part of BCA, it poses problems in that potential compensation may not be actual compensation.
Obviously, BCA is most appropriate when both benefits and costs can be tangibly measured in monetary terms. Nevertheless, some researchers warn that quantification shouldn't be the sole basis for performing a benefit-cost analysis. They contend that just because some important factors are not easily measured, they should not be ignored or given a lesser value than factors that can be measured. For example, how can you accurately quantify the human pain and suffering by people with severe back pain or chronic depression? In essence, BCA doesn't pretend to introduce rigor and quantification when data originate on subjectivity, imprecision, or where quantification is not feasible. However, when costs and benefits can be quantified, a BCA can be used to judge the worth of a single intervention or provide comparisons on two or more interventions.
Overall, benefit-cost analysis provides meaningful data to the extent that any benefits can be accurately
measured. Yet such noble benefits as human lives saved, preventing heart attacks, or easing chronic back pain are not easily translated into precise numbers. Interestingly, a human life was valued to be worth a mere $5,000 nearly a Century ago. M oreover, should a monetary value even be placed on a human life? Although it is possible to calculate the direct costs of treating a heart attack victim or to discount a person's future job earnings lost from a disability, try to imagine the technical and ethical implications of using a benefit-cost analysis beyond its intended scope.
Performing a Benefit-Cost Analysis
The cost side of a benefit-cost analysis involves calculating the costs of all resources used in planning and implementing an intervention. In contrast, the benefit side of the equation involves calculating the 
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Presumably, calculating "direct" benefits associated with an intervention should be relatively simple.
However, before any benefit can be calculated, evaluators must select benefit variables that are accessible and measurable, and feel confident that any benefit outcome is due primarily to the intervention. After all costs and benefits have been identified and measured, the two categories are monetarily compared. In most cases, the goal is to determine the "net benefit" of a particular intervention. In essence, if the value of the benefits minus the value of the costs is positive, then the analysis would indicate that the intervention is financially "worth the effort."
The net benefit of any intervention may be viewed in the following manner:
∑L$ (sometimes called the direct benefit) stands for the reduction in 6 medical care expenses due to a reduction of disease or disability.
For example, if the incidence of low back injury declines, then some of the spending on physicians and other medical care services will no longer be necessary and, thus, "saved" by the employer, society, or other payers.
∑GP stands for the increase in general productivity, leading to greater output and income. For example, if we reduce the incidence of low back injury, we also increase the performance capabilities of the persons involved (e.g., uninjured workers are more productive than injured workers) so that they may continue to produce at desirable levels and earn their full paycheck.
∑PI stands for the gain in working income due to reduced illness and injury and their effects on absenteeism (lost income). Overall, GP and PI are the "indirect benefits.
C stands for the cost of the intervention [e.g., a nurse practitioner].
Using a BCA framework, the cost of the NP placement was compared to any reduction in the firm's actual 2004 medical costs vs. the firm's projected 2004 medical care costs.
Results
The official date in which NP services were initiated at the firm was Table 2 . Table 3 provides a head-to-head comparison between the two scenarios. • Actual payments were 18.5 lower than the projected norm.
• Actual per capita claims were more than 24 % lower than the projected utilization norm
• Actual per capita payments were more than 14% lower than the projected payment norm were not available, and (2) how many days per year they estimated that they came to work because there was an on-site medical clinic when they would otherwise have stay at home. The results indicated that, on average, employees who used the facility saved 3.3 days of absenteeism. In addition, nearly 70% of employees indicated that they would have sought attention elsewhere, suggesting that the presence of an on-site medical center does not induce demand. The preceding benefit-to-cost ratio indicates the initial phase of the NP intervention generated a favorable level of cost-containment benefits at the firm. Yet, it should be noted that the 2004 claims and payment data were based on eleven (11) months of actual data and, thus, did not include claims and payments for the month of December. Although C&A extrapolated 11 months of data into an annual (full year) projection, there is some evidence that claims and payments are higher in the winter months than in other months. [6] [7] Thus, the only way to determine the most accurate benefit-to-cost ratio -within this initial methodological approachwould be to obtain all claims and payments relevant to the month of December. Statistically speaking, the preceding benefit-to-cost ratio of 15.88 to 1 would, at worst, be reduced no more than 1/12 th -based on the liberal assumption that utilization and payment patterns are twice as high in December as in preceding months.
Even then, the ratio would be reduced to 14.55 to 1.
As with any project in which econometric analyses are involved, it is important to compare the initial cost-to-benefit findings with those from another evaluative approach to objectively judge how the independent approaches differ and what, if any, contrasting outcomes result. This project lends itself to such options that can provide decision-makers with at least two alternative methods to evaluate the impact of the NP intervention.
A S econd Analysis
Unlike the preceding approach which is a macro-analytical overview and comparison of projected vs.
actual claims and costs conducted on an aggregate [group] population, this second approach was a bit more micro-analytical in that it takes into account:
• Actual conditions reported by individual employees within each of the three worksite locations • Estimated costs for the preceding conditions if they were treated off-site [without NP treatment]
• A cost comparison between treatments per specific condition without NP vs. with the NP Key procedures used to factor in the preceding components were undertaken in the following order:
( Since virtually all of the conditions treated by the NP appeared to be acute and minor ailments, 5 The firm's estimated cost-savings if treatments were rendered by an on-site nurse practitioner rather than offsite health care providers.
Overall, specific M DCs responsible for the greatest cost-savings potential were circulatory (25%), respiratory (17%), and skin and subcutaneous (13%).
The final computation conducted in this alternative analysis was a head-to-head dollar comparison of the annual cost for the nurse practitioner compared to the estimated annual cost-savings. Comparing direct costs tied to an annual placement of a nurse practitioner at the firm with the estimated "cost-savings" yields the following:
Cost-savings $ 197,550 $ 1.00
Overall, the preceding micro-analytical review of costs and benefits indicates the firm is saving $1 for every 42 cents spent for on-site nurse practitioner services -or a savings-to-cost ratio of 2.38 to 1.
In summary, this micro-analytical review of the NP placement indicates a more conservative, yet favorable, cost-to-benefit ratio than the initial macro-analytical approach.
Overall, the financial comparisons described and illustrated on the preceding pages reveal the following benefit-to-cost ratios and return-on-investment percentages:
Benefit and to previous year actual costs. It is also possible, however, that these initiatives may experience some adverse outcomes with negative monetary or other consequences that did not occur during this start-up phase.
Should such occur, the reactions on the part of attending physicians of the involved workers or family members could be quite negative. However, we endeavor to consult with personal physicians in all cases where other than minor illnesses occur, and to refer worker-patients promptly in such cases. Often, the workers do not have personal physicians, in which cases we identify such resources convenient to their homes and arrange for early appointments.
The M DC analysis we employed also carries certain limitations. For example, the $500 cut-off for claim costs may give an obvious disadvantage to the NP. The real savings of an on-site NP program may be in preventing claims that have escalated unnecessarily, either by early treatment and prevention, or by preventing trips to a hospital emergency room. Furthermore, these small claims represented a small percentage of toal costs, thus raising doubt if an on-site NP program would, in actuality and over time, be limited to only impacting a small subset of total claims and costs.
As an additional limitation, our experience with the NP and NHL programs may lack general applicability, being based in three urban North Carolina locations of a single company engaged in the foundry and plastic business, and which had on-site Occupational Health Nurses at both of its manufacturing sites. M any of the employees of the company live at substantial distances from the worksites, driving an hour or more each way. At times, long working hours make it difficult for individual workers to access health care off-site. Our findings may therefore not apply to other groups of workers with different logistics and personal habits. Other employers will need to make careful assessments of the benefits and possible disadvantages of on-site programs similar to the ones described herein.
From the perspective of health care organizations, it may seem counter-intuitive for such an entity to help design and implement lower-cost options for delivering such care, as well as preventive medicine measures.
However, it strikes us as essential that those entrusted with the care of the community must support efforts to improve such care and to optimize its benefit-to-cost function. And, to do so in measurable ways. CHS therefore plans to continue its efforts to partner with employers in this regard, including optimizing the deployment of NP, NHL and other health professionals at all sites where they practice their expertise. 
